(Q34433818)

2 August 2017

title

Effect of itopride, a new prokinetic, in patients with mild GERD: a pilot study (English)

1 reference

2 August 2017

Yong Sung Kim

1

1 reference

2 August 2017

Tae Hyeon Kim

2

1 reference

2 August 2017

Chang Soo Choi

3

1 reference

2 August 2017

Young Woo Shon

4

1 reference

2 August 2017

Sang Wook Kim

5

1 reference

2 August 2017

Geom Seog Seo

6

1 reference

2 August 2017

Yong Ho Nah

7

1 reference

2 August 2017

Myung Gyu Choi

8

1 reference

2 August 2017

Suck Chei Choi

9

1 reference

2 August 2017

language of work or name

English

0 references

publication date

1 July 2005

1 reference

World Journal of Gastroenterology

2 August 2017

published in

1 reference

2 August 2017

volume

11

1 reference

2 August 2017

issue

27

1 reference

2 August 2017

page(s)

4210-4214

1 reference

Overview of medical therapy for gastroesophageal reflux disease

2 August 2017

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4615444

Updated guidelines for the diagnosis and treatment of gastroesophageal reflux disease. The Practice Parameters Committee of the American College of Gastroenterology

6 July 2018

2 references

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4615444

6 July 2018

https://api.crossref.org/works/10.3748%2FWJG.V11.I27.4210

The effect of mosapride, a novel prokinetic, on acid reflux variables in patients with gastro-oesophageal reflux disease

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4615444

Cisapride 20 mg b.i.d. provides symptomatic relief of heartburn and related symptoms of chronic mild to moderate gastroesophageal reflux disease. CIS-USA-52 Investigator Group

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4615444

A prokinetic approach to treatment of gastroesophageal reflux disease

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4615444

Does oesophageal motor function improve with time after successful antireflux surgery? Results of a prospective, randomised clinical study

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4615444

Review article: promotility drugs in the treatment of gastro-oesophageal reflux disease.

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4615444

Effect of cisapride on the gastro-oesophageal function in normal human subjects.

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4615444

Combined therapy with cisapride and cimetidine in severe reflux oesophagitis: a double blind controlled trial

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4615444

Cisapride restores the decreased lower oesophageal sphincter pressure in reflux patients

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4615444

Effect of cisapride on postprandial gastro-oesophageal reflux

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4615444

Dopamine in gastrointestinal disease

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4615444

Cisapride for gastroesophageal reflux disease: a placebo-controlled, double-blind study

6 July 2018

1 reference

12 December 2020

Is Motility Impaired in the Entire Upper Gastrointestinal Tract in Patients with Gastro-oesophageal Reflux Disease?

1 reference

12 December 2020

Stimulatory effect of N-[4-[2-(dimethylamino)-ethoxy] benzyl]-3,4-dimethoxybenzamide hydrochloride (HSR-803) on normal and delayed gastrointestinal propulsion

1 reference

12 December 2020

A novel water-soluble dopamine-2 antagonist with anticholinesterase activity in gastrointestinal motor activity. Comparison with domperidone and neostigmine

1 reference

12 December 2020

Metoclopramide therapy in fifty-five patients with delayed gastric emptying

1 reference

12 December 2020

Effect of cisapride, a new prokinetic agent, on esophageal motor function

1 reference

12 December 2020

Identifiers

DOI

10.3748/WJG.V11.I27.4210

1 reference

2 August 2017

1 reference

2 August 2017

1 reference